N-cyclohexyl-2-{8-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl}acetamide
N-环己基-2-{8-[3-(4-甲基苯基)-1,2,4-噁二唑-5-基]-3-氧代[1,2,4]三唑并[4,3-a]吡啶-2(3H)-基}乙酰胺
N-cyclohexyl-2-{8-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl}acetamide (CAS 1260927-63-6) is a compound in the Pharma Intermediates category listed in the Jingsj chemical database. It has the molecular formula C23H24N6O3 and a molecular weight of 432.5 g/mol. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.
- CAS No.
- 1260927-63-6
- Jingsj CID
- J-520340-4
- Molecular Formula
- C23H24N6O3
- Chinese Name
- N-环己基-2-{8-[3-(4-甲基苯基)-1,2,4-噁二唑-5-基]-3-氧代[1,2,4]三唑并[4,3-a]吡啶-2(3H)-基}乙酰胺
- Molecular Weight
- 432.5 g/mol
- Category
- Pharma Intermediates
- Last updated
- 8/21/2026
No offers for this compound yet.
Request a quoteFrequently Asked Questions
What is the CAS number of N-cyclohexyl-2-{8-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl}acetamide?
The CAS number of N-cyclohexyl-2-{8-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl}acetamide is 1260927-63-6.
What are the molecular formula and molecular weight of N-cyclohexyl-2-{8-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl}acetamide?
N-cyclohexyl-2-{8-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl}acetamide has molecular formula C23H24N6O3 and molecular weight 432.5 g/mol.
Data compiled from public chemical databases and supplier catalogs; supplier offers are provided by suppliers.
Last updated:
How to cite: Jingsj. "N-cyclohexyl-2-{8-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl}acetamide (CAS 1260927-63-6)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-520340-4 (accessed 2026-10-24).
Data for reference only; verify specifications, grades and regulatory status with suppliers before purchase.